Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortization of Goodwill Amortization of Goodwill Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Dividends Paid - Common Dividends Paid - Common Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Repurchased Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances

Daily Values

Growth Metrics

AdaptHealth (AHCO) Gains from Sales and Divestitures (2020 - 2022)

AdaptHealth has reported Gains from Sales and Divestitures over the past 3 years, most recently at $461000.0 for Q3 2022.

For Q3 2022, Gains from Sales and Divestitures rose 37.61% year-over-year to $461000.0; the TTM value through Sep 2022 reached $461000.0, up 37.61%, while the annual FY2021 figure was $556000.0, 344.8% up from the prior year.
Gains from Sales and Divestitures for Q3 2022 was $461000.0 at AdaptHealth, up from $350000.0 in the prior quarter.
Over five years, Gains from Sales and Divestitures peaked at $556000.0 in Q4 2021 and troughed at $15417.0 in Q1 2020.
A 3-year average of $219219.7 and a median of $156000.0 in 2021 define the central range for Gains from Sales and Divestitures.
Biggest five-year swings in Gains from Sales and Divestitures: soared 680.0% in 2021 and later soared 37.61% in 2022.
Year by year, Gains from Sales and Divestitures stood at $125000.0 in 2020, then skyrocketed by 344.8% to $556000.0 in 2021, then fell by 17.09% to $461000.0 in 2022.
Business Quant data shows Gains from Sales and Divestitures for AHCO at $461000.0 in Q3 2022, $350000.0 in Q2 2022, and $230000.0 in Q1 2022.